Predictive modeling of antioxidant coumarin derivatives using multiple approaches: Descriptor-based QSAR, 3D-pharmacophore mapping, and HQSAR

Scientia Pharmaceutica

Volumn 81, Issue 1, 2013, Pages 57-80

  Mitra, Indrani ^a   Saha, Achintya ^b   Roy, Kunal ^a  

^a JADAVPUR UNIVERSITY   (India)

^b UNIVERSITY OF CALCUTTA   (India)

Author keywords

Antioxidant; HQSAR; Pharmacophore; QSAR

Indexed keywords

ANTIOXIDANT; COUMARIN DERIVATIVE; FREE RADICAL;

ANTIOXIDANT ACTIVITY; ARTICLE; BIOLOGICAL ACTIVITY; CHEMOMETRIC ANALYSIS; COMPUTER MODEL; COMPUTER PROGRAM; CORRELATION COEFFICIENT; DRUG STRUCTURE; ELECTRON TRANSPORT; HYDROGEN BOND; HYDROPHOBICITY; IC 50; PHARMACOPHORE; PREDICTION; QUANTITATIVE STRUCTURE ACTIVITY RELATION; RANDOMIZATION; VALIDATION PROCESS;

EID: 84875298359     PISSN: 00368709     EISSN: 22180532     Source Type: Journal    
DOI: 10.3797/scipharm.1208-01     Document Type: Article

References (39)

1. St-Pierre J. Topology of superoxide production from different sites in the mitochondrial electron transport chain. J Biol Chem. 2002; 277: 44784-44790. http://dx.doi.org/10.1074/jbc.M207217200
2. Evans MD, Cooke MS. Factors contributing to the outcome of oxidative damage to nucleic acids. Bioassays. 2004; 26: 533-542. http://dx.doi.org/10.1002/bies.20027
3. Brunk UT, Terman A. The mitochondrial-lysosomal axis theory of aging: accumulation of damaged mitochondria as a result of imperfect autophagocytosis. Eur J Biochem. 2002; 269: 1996-2002. http://dx.doi.org/10.1046/j.1432-1033.2002.02869.x
4. Salvi A, Carrupt PA, Tillement JP, Testa B. Structural damage to proteins caused by free radicals: asessment, protection by antioxidants, and influence of protein binding. Biochem Pharmacol. 2001; 61: 1237-1242. http://dx.doi.org/10.1016/S0006-2952(01)00607-4
5. Belch JJF, Chopra M, Hutchison S, Lorimer R, Sturrock RD, Forbes CD, Smith WE. Free radical pathology in chronic arterial disease. Free Rad Biol Med. 1989; 6: 375-378. http://dx.doi.org/10.1016/0891-5849(89)90082-8
6. Rowe GT, Eaton LR, Hess ML. Neutrophil-derived, oxygen free radical-mediated cardiovascular dysfunction. J Mol Cell Cardiol. 1984; 16: 1075-1079. http://dx.doi.org/10.1016/S0022-2828(84)80020-6
7. Stocker R, Keaney JF Jr. Role of Oxidative Modifications in Atherosclerosis. Physiol Rev. 2004; 84: 1381-1478. http://dx.doi.org/10.1152/physrev.00047.2003
8. Nuttall SL, Kendall MJ, Martin U. Antioxidant therapy for the prevention of cardiovascular disease. QJM. 1999; 92: 239-244. http://dx.doi.org/10.1093/qjmed/92.5.239
9. Ueda T, Ueda T, Armstrong D. Preventive effect of natural and synthetic antioxidants on lipid peroxidation in the mammalian eye. Ophthalmic Res. 1996; 28: 184-192. http://dx.doi.org/10.1159/000267901
10. Bast A, Haenen GRMM, Bruynzeel AME, van der Vijgh WJF. Protection by flavonoids against anthracycline cardiotoxicity: from chemistry to clinical trials. Cardiovasc Toxicol. 2007; 7: 154-159. http://dx.doi.org/10.1007/s12012-007-0018-0
11. Helguera AM, Combes RD, Gonzalez MP, Cordeiro MN. Applications of 2D descriptors in drug design: a DRAGON tale. Curr Top Med Chem. 2008; 8: 1628-1655. http://dx.doi.org/10.2174/156802608786786598
12. Pérez-Garrido A, Helguera AM, Ruiz JMM, Rentero PZ. Topological sub-structural molecular design approach: Radical scavenging activity. Eur J MedChem. 2012; 49: 86-94. http://dx.doi.org/10.1016/j.ejmech.2011.12.030
13. Li YW, Li B, He J, Qian P. Quantitative structure-activity relationship study of antioxidative peptide by using different sets of amino acids descriptors. J Mol Str. 2011; 998: 53-61. http://dx.doi.org/10.1016/j.molstruc.2011.05.011
14. Mitra I, Saha A, Roy K. In silico development, validation and comparison of predictive QSAR models for lipid peroxidation inhibitory activity of cinnamic acid and caffeic acid derivatives using multiple chemometric and cheminformatics tools. J Mol Model. 2012; 18: 3951-3967. http://dx.doi.org/10.1007/s00894-012-1392-5
15. Mitra I, Saha A, Roy K. Development of multiple QSAR models for consensus predictions and unified mechanistic interpretations of the free-radical scavenging activities of chromone derivatives. J Mol Model. 2012; 18: 1819-1840. http://dx.doi.org/10.1007/s00894-011-1198-x
16. Roy K, Mitra I, Saha A. Molecular shape analysis of antioxidant and squalene synthase inhibitory activities of aromatic tetrahydro-1, 4-oxazine derivatives. Chem Biol Drug Des. 2009; 74: 507-516. http://dx.doi.org/10.1111/j.1747-0285.2009.00888.x
17. Mitra I, Saha A, Roy K. Quantitative structure-activity relationship modeling of antioxidant activities of hydroxybenzalacetones using quantum chemical, physicochemical and spatial descriptors. Chem. Biol. Drug Des. 2009; 73: 526-536. http://dx.doi.org/10.1111/j.1747-0285.2009.00801.x
18. Beillerot A, Dominguez JCR, Kirsch G, Bagrel D. Synthesis and protective effects of coumarin derivatives against oxidative stress induced by doxorubicin. Bioorg Med Chem Lett. 2008; 18: 1102-1105. http://dx.doi.org/10.1016/j.bmcl.2007.12.004
19. Meneghini R. Iron homeostasis, oxidative stress, and DNA damage. Free Radic Biol Med. 1997; 23: 783-792. http://dx.doi.org/10.1016/S0891-5849(97)00016-6
20. Ferrari AM, Sgobba M, Gamberini MC, Rastelli G. Relationship between quantum-chemical descriptors of proton dissociation and experimental acidity constants of various hydroxylated coumarins. Identification of the biologically active species for xanthine oxidase inhibition. Eur J Med Chem. 2007; 42: 1028-1031. http://dx.doi.org/10.1016/j.ejmech.2006.12.023
21. Guner OF, ed. HypoGen: an automated system for generating 3D predictive pharmacophore models. In: Pharmacophore perception, development, and use in drug design. La Jolla: International University Line, 2000: 501-511.
22. Waller CL. A comparative QSAR study using CoMFA, HQSAR, and FRED/SKEYS paradigms for estrogen receptor binding affinities of structurally diverse compounds. J Chem Inf Comput Sci. 2004; 44: 758-765. http://dx.doi.org/10.1021/ci0342526
23. Zhang Y, Zou B, Chen Z, Pan Y, Wang H, Liang H, Yi X. Synthesis and antioxidant activities of novel 4-Schiff base-7-benzyloxy-coumarin derivatives. Bioorg Med Chem Lett. 2011; 21: 6811-6815. http://dx.doi.org/10.1016/j.bmcl.2011.09.029
24. Cavar S, Kovac F, Maksimovic M. Synthesis and antioxidant activity of selected 4-methylcoumarins. Food Chem. 2009; 117: 135-142. http://dx.doi.org/10.1016/j.foodchem.2009.03.087
25. Panteleon V, Kostakis IK, Marakos P, Pouli N, Andreadou I. Synthesis and free radical scavenging activity of some new spiropyranocoumarins. Bioorg Med Chem Lett. 2008; 18: 5781-5784. http://dx.doi.org/10.1016/j.bmcl.2008.09.065
26. Cerius2, version 4.10. 2005, Accelrys Inc., San Diego, CA.
27. Everitt B, Landau S, Leese M. Cluster analysis. London: Arnold, 2001.
28. Rogers D, Hopfinger AJ. Application of genetic function approximation to quantitative structure-activity relationships and quantitative structure-property relationships. J Chem Inf Comput. Sci. 1994; 34: 854-866. http://dx.doi.org/10.1021/ci00020a020
29. Wold S, Sjostrom M, Eriksson L. PLS-regression: a basic tool of chemometrics. Chemom Intell Lab Syst. 2001; 58: 109-130. http://dx.doi.org/10.1016/S0169-7439(01)00155-1
30. Discovery Studio, version 2.1. 2010, Accelrys Inc., San Diego, CA.
31. Smellie A, Teig SL, Towbin P. Poling: promoting conformational variation. J Comput Chem. 1995; 16: 171-187. http://dx.doi.org/10.1002/jcc.540160205
32. Sybyl, vrsion 7.3. 2006, Tripos Inc., St. Louis. www.tripos.com
33. Kubiniyi H, ed. PLS: partial least squares projections to latent structures. In: 3D QSAR in drug design: theory methods and applications. Leiden: ESCOM, 1993: 523-550.
34. Ojha PK, Mitra I, Das RN, Roy K. Further exploring rm2 metrics for validation of QSPR models. Chemom Intell Lab Syst. 2011; 107: 194-205. http://dx.doi.org/10.1016/j.chemolab.2011.03.011
35. Roy K, Mitra I, Kar S, Ojha P, Das RN, Kabir H. Comparative studies on some metrics for external validation of QSPR models. J Chem Inf Model. 2012; 52: 396-408. http://dx.doi.org/10.1021/ci200520g
36. Golbraikh A, Tropsha A. Beware of q2! J Mol Graph Model. 2002; 20: 269-276. http://dx.doi.org/10.1016/S1093-3263(01)00123-1
37. Mitra I, Saha A, Roy K. Exploring quantitative structure-activity relationship (QSAR) studies of antioxidant phenolic compounds obtained from traditional Chinese medicinal plants. Mol Simul. 2010; 36:1067-1079. ttp://dx. doi.org/10.1080/08927022.2010.503326
38. Viswanadhan VN, Ghose AK, Reyankar GR, Robins RK. Atomic physicochemical parameters for three dimensional structure directed quantitative structure-activity relationships. 4. Additional parameters for hydrophobic and dispersive interactions and their application for an automated superposition of certain naturally occurring nucleoside antibiotics. J Chem Inf Comput Sci. 1989; 29: 163-172. http://dx.doi.org/10.1021/ci00063a006
39. Wright JS, Johnson ER, Dilabio GA. Predicting the activity of phenolic antioxidants: theoretical method, analysis of substituent effects, and application to major families of antioxidants. J Am Chem Soc. 2001; 123: 1173-1183. http://dx.doi.org/10.1021/ja002455u